FDA’s Mobile Health Guidance Removes Risk For Investors
This article was originally published in Start Up
Investors and their limited partners really don’t like risk, especially not the kind due to uncertainty. Now, for developers of mobile health applications and their investors, at least one risk has been taken off the table: regulatory uncertainty. On September 23, the FDA published the much-anticipated final guidance on mobile medical apps.
Register for our free email digests: